Alpha-glucosidase inhibitors: all 69 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM PatientsNot yet recruitingNCT05688332Phase 3
• Study of Acarbose in LongevityTerminatedNCT02953093Phase 2Results posted
• Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)CompletedNCT02865499Phase 2Results posted
• Postmarketing Clinical Study on AO-128CompletedNCT02287402Phase 4Results posted
• Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCompletedNCT02049814Phase 4Results posted
• A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01777282Phase 3Results posted
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
• Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM PatientsCompletedNCT01490918Phase 4Results posted
• Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263509Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263483Phase 2/3Results posted
• Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedNCT01181674Phase 4Results posted
• Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood ObesityTerminatedNCT00846521Phase 4Results posted
• MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)CompletedNCT00837577Phase 3Results posted
• CGM-Guided Acarbose for Painful Diabetic NeuropathyCompletedNCT07436585Phase 1
• Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownNCT05629806Phase 3
• The Efficacy and Tolerability of Acarbose in Healthy IndividualsCompletedNCT05542849Phase 4
• Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)WithdrawnNCT05487859Phase 2
• Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and AcarboseCompletedNCT05035849Not applicable
• Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownNCT04287387Phase 4
• Bioequivalence Study for Acarbose/Metformin FDCCompletedNCT04065581Phase 1
• Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.Status unknownNCT03961659Not applicable
• Research of Intensive Metabolic Intervention Before Pregnancy in PCOSStatus unknownNCT03383068Phase 4
• Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.TerminatedNCT03380546Phase 3
• Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedNCT03359837Phase 4
• Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsCompletedNCT03349684Phase 3
• Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesCompletedNCT03241303Not applicable
• Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownNCT02999841Phase 4
• Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 DiabetesStatus unknownNCT02605772Phase 4
• Human Oral Detection of Glucose OlygomersCompletedNCT02589353Phase 4
• Research of Intensive Lifestyle Intervention for PCOS Patients With IGTCompletedNCT02446834Not applicable
• the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix InsulinStatus unknownNCT02438397Phase 4
• Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant PatientsCompletedNCT02355509Phase 4
• Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 DiabetesCompletedNCT02315495Phase 3
• Acarbose, Postprandial Hypotension and Type 2 DiabetesCompletedNCT02043886Phase 2
• Acarbose and Older Adults With Postprandial HypotensionCompletedNCT01914133Phase 2
• Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery DiseaseCompletedNCT01863147Phase 4
• Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 DiabetesStatus unknownNCT01758471Phase 4
• Bioequivalence Study for Acarbose / Metformin FDCCompletedNCT01728740Phase 1
• A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mgCompletedNCT01554631Phase 1
• Early Diabetes Intervention ProgramCompletedNCT01470937Phase 4
• A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard TabletCompletedNCT01388153Phase 1
• Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesCompletedNCT01309698Phase 4
• Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)CompletedNCT01279512Phase 4
• A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes MellitusStatus unknownNCT01245166Phase 3
• A Study to Assess Drug-Drug Interaction Between ASP1941 and MiglitolCompletedNCT01099839Phase 1
• The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
• Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary CareCompletedNCT01010100Phase 3
• Vildagliptin and Endothelium-dependent VasodilatationCompletedNCT01000688Phase 3
• Glucose Reduction by Early Acarbose Treatment in Basal InsulinCompletedNCT00970528Phase 4
• Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)Status unknownNCT00858676Phase 4
• Acarbose Cardiovascular Evaluation TrialCompletedNCT00829660Phase 4
• Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.Status unknownNCT00724542Not applicable
• A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00677521Phase 2
• Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM TrialCompletedNCT00629213Phase 3
• Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
• AI(I)DA Acarbose and the Subclinical InflammationCompletedNCT00558883Phase 3
• Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 DiabetesCompletedNCT00551954Phase 3
• The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic PatientsCompletedNCT00437918Phase 4
• Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 DiabetesStatus unknownNCT00417950Not applicable
• Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DMCompletedNCT00417729Phase 4
• Double-Blind Study of Miglitol in Japanese With type2 DiabetesCompletedNCT00380822Phase 3
• Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideCompletedNCT00334503Phase 3
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideCompletedNCT00334399Phase 3
• Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
• Acarbose and Secondary Prevention After Coronary StentingCompletedNCT00221156Phase 3
• Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With InsulinCompletedNCT00213122Phase 3
• Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin TreatmentCompletedNCT00213109Phase 3
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentCompletedNCT00213070Phase 3
• Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGTTerminatedNCT00212017Not applicable

← Alpha-glucosidase inhibitors overview